Page 391 - fbkCardioDiabetes_2017
P. 391

Cardio Diabetes Medicine 2017                                   367






                                    Cardiac  MRI  vs  PET  Scan







                                                    Dr. G. N. Mahapatra

                                          Senior  Consultant & Head, Dept of Nuclear Medicine,
                                                         PET-CT & SPECT-CT
                                           Seven Hills  Hospital  (JCI USA  accredited), Mumbai.





                 Introduction :                                     Clinical Uses in day to day Practice:
                 CAD is among the major public health issues across    Cardiac MRI (CMR) is a non-invasive diagnostic tool
                 the globe  &  is  still  largely  perceived  as  a conse-  which can be used for morphology , function, viability
                 quence of the  incremental  occlusion  of coronary   & perfusion assessment  in coronary artery  disease
                 arteries  through progressive vascular stenosis  that   (CAD)  &  other  important infiltrative diseases  of  the
                 can  be  diagnosed  by  coronary  angiography  &  treat-  myocardium .
                 ed by percutaneous or surgical coronary revascular-
                 ization. Today  an unreasonable a large  number of  Clinical Uses of Cardiac MRI Vs PET Scan in
                 symptomatic &  asymptomatic at risk  patients with   CAD :
                 suspected CAD  with  risk  factors such  as diabetes
                 mellitus, hypertension, dyslipidemia,  tobacco  smok-  i)Rest &  Stress  CMR myocardial  perfusion  imaging
                 ing  /consuming  either  through Paan or  cigarettes   (MPI) Vs PET Stress –Rest MPI.
                 will undergo coronary angiography . Another subset   ii)LGE or dobutamine stress CMR Vs PET F-18, FDG or
                 of patients having 100%  blockage  in the major cor-  Rb-82 or N-13 Ammonia, radiotracers in the assess-
                 onary arteries  has been also revascularized without   ment of myocardial viability.
                 accessing myocardial viability.  Several  large  ran-
                 domized trials have emphasized the limitations of   Clinical Uses of Cardiac MRI Vs PET Scan in infiltrative
                 coronary  arteriography  studies  that  lead  to thera-  Cardiac Diseases.
                 peutic interventions  based  only  on the morphologic   i)Cardiac MRI Vs PET Scan in sarcoidosis ,Amyloido-
                 severity  of epicardial  coronary stenosis,  these trials   sis, Tuberculosis.
                 advocate  for additional  proof of haemodynamically
                 significant stress induced reduction in coronary flow  1.Rest & Stress CMR Myocardial Perfusion
                 before any therapeutic interventions are undertaken.   Imaging (MPI) Vs PET Stress-Rest MPI :
                 At the clinician’s disposal is a large armamentarium
                 of tests including treadmill stress  test,  stress  MPI,    CMR is a non-invasive diagnostic stool that does not
                 stress ECHO, stress PET, CT coronary angiography &   require  ionizing radiation &  can  be used to assess
                 cardiac magnetic resonance imaging (CMR). Though   myocardial perfusion  abnormalities using Gadolini-
                 all are available  for the diagnosis  & prognostication   um based contrast agent in a dose of 0.1 mmol/per
                 of patients with suspected and documented coronary   Kg of body weight at a rate of 5ml/min. This agent
                 artery  disease  (CAD)  , selecting  the “best  test” can   has very  low nephrotoxicity. Immediately after the
                 be  daunting to clinicians. And understanding of  the   injection  of the  contrast  agent,  images  for myocar-
                 patient population, patient pretest probability of CAD   dial perfusion study is obtained. After a gap of 10-15
                 , the risk benefits and limitations of each technology   minutes , i.v. Adenosine  infusion with 140 mg/Kg/
                 will enable the medical imaging professional to assist   min for period of 3 minute is administered following
                 clinicians with test selection.                    which  Gadolinium DTPA  is  injected at a rate  of 0.1
                                                                    mmol/per  Kg  of  body  weight  at a rate  of  5ml/min,
                                                                    followed by 3 min of adenosine infusion is continued.
                                                                    Late  Gadolinium enhancement (LGE) imaging  study



                                                    Cardio Diabetes Medicine
   386   387   388   389   390   391   392   393   394   395   396